The Executive Oncology Account Manager (OAM) is a field-based individual contributor responsible for driving the successful launch and commercialization of ivonescimab within an assigned U.S. territory. The role develops and executes territory-level business plans, builds customer relationships, and achieves sales objectives aligned with national and regional commercial strategies. The OAM engages oncology customers across community practices, academic centers, integrated delivery networks, and other key accounts to support appropriate product education and access. The role reports to a Regional Business Director and collaborates with Marketing, Market Access, Medical Affairs, Commercial Operations, and regional leadership to support customer experience and business performance. Summit Therapeutics Inc. is a biopharmaceutical oncology company focused on improving quality of life, increasing potential duration of life, and addressing serious unmet medical needs. Its clinical programs include global Phase 3 studies in non-small cell lung cancer and colorectal cancer. Ivonescimab is investigational and is not approved by a regulatory authority other than China’s National Medical Products Administration (NMPA). Summit is headquartered in Miami, Florida, with additional offices in California, New Jersey, the UK, and Ireland. The role is based in Oakland, California, and is field-based. Compensation is listed at $210,000–$220,000 USD. Actual compensation may vary based on candidate-specific factors and work location. The total compensation package may also include bonus, stock, benefits, and/or other applicable variable compensation.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Senior